Name: Ulixacaltamide in Essential tremor: Prevalence of Essential tremor
Published: 2026-09-14T15:39:06-04:00

Product information and disease description Place of product in therapy Disease description Epidemiology

Prevalence of Essential tremor

3 evidence topics · 4 sources

Estimated US prevalence including undiagnosed disease

“ET cases (2012) ranged from 6.38 to 7.63 million (mean = 7.01 million).” (opens the source at this quote in a new tab)
“This corresponds to approximately 2.2% of the US population.” (opens the source at this quote in a new tab)

Prevalence of diagnosed disease

“After standardization, prevalence was 0.42%; in 2024, 1.1 million US adults were estimated to have diagnosed ET.” (opens the source at this quote in a new tab)

Prevalence by ascertainment strategy in northeast-central Pennsylvania

Ascertainment strategy	Crude prevalence	Age-standardized prevalence
Neurology cohort	“0.261% (95% CI, 0.252–0.271)”	“0.40% (95% CI, 0.39–0.41)”
All-specialties cohort	“0.653% (95% CI, 0.638–0.668)”	“1.01% (95% CI, 1.00–1.02)”